speb/financial-data huggingface dataset:
AMSC income_statement (annual, 2026-03-31) — Operating Revenue: 299155000.00
AMSC income_statement (quarterly, 2026-03-31) — Operating Revenue: 86406000.00
AMSC balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 47632340.00
AMSC balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 47632340.00
AMSC balance_sheet (annual, 2026-03-31) — Other Current Assets: 14367000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 14367000.00
AMSC balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 12808000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 12808000.00
AMSC balance_sheet (annual, 2026-03-31) — Other Equity Adjustments: 4072000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 4072000.00
AMSC income_statement (annual, 2026-03-31) — Other Income Expense: -5224000.00
AMSC income_statement (quarterly, 2026-03-31) — Other Income Expense: -5281000.00
AMSC balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 13548000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 13548000.00
AMSC balance_sheet (annual, 2026-03-31) — Other Inventories: 7579000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Other Inventories: 7579000.00
AMSC cash_flow (annual, 2026-03-31) — Other Non Cash Items: 4487000.00
AMSC cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 4390000.00
AMSC balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 4341000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 4341000.00
AMSC balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 27350000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 27350000.00
AMSC income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: -1053000.00
AMSC income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1110000.00
AMSC balance_sheet (annual, 2026-03-31) — Other Properties: 3897000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Other Properties: 3897000.00
AMSC balance_sheet (annual, 2026-03-31) — Other Receivables: 14875000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Other Receivables: 14875000.00
AMSC balance_sheet (annual, 2026-03-31) — Payables: 13656000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Payables: 13656000.00
AMSC balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 27536000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 27536000.00
AMSC balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15518000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15518000.00
AMSC income_statement (annual, 2026-03-31) — Pretax Income: 16748000.00
AMSC income_statement (quarterly, 2026-03-31) — Pretax Income: -474000.00
AMSC cash_flow (annual, 2026-03-31) — Proceeds From Stock Option Exercised: 391000.00
AMSC cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 149000.00
AMSC balance_sheet (annual, 2026-03-31) — Properties: 0.00
AMSC balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
AMSC cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 3497000.00
AMSC cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 1335000.00
AMSC cash_flow (annual, 2026-03-31) — Purchase Of Business: -72096000.00
AMSC cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
AMSC cash_flow (annual, 2026-03-31) — Purchase Of PPE: -4888000.00
AMSC cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1789000.00
AMSC balance_sheet (annual, 2026-03-31) — Raw Materials: 54247000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Raw Materials: 54247000.00
AMSC balance_sheet (annual, 2026-03-31) — Receivables: 69381000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Receivables: 69381000.00
AMSC income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 201693000.00
AMSC income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 60548000.00
AMSC income_statement (annual, 2026-03-31) — Reconciled Depreciation: 8454000.00
AMSC income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3445000.00
AMSC cash_flow (annual, 2026-03-31) — Repayment Of Debt: -8809000.00
AMSC cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -7926000.00
AMSC cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: 0.00
AMSC cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
AMSC income_statement (annual, 2026-03-31) — Research And Development: 15744000.00
AMSC income_statement (quarterly, 2026-03-31) — Research And Development: 4167000.00
AMSC balance_sheet (annual, 2026-03-31) — Restricted Cash: 3548000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 3548000.00
AMSC income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: 4171000.00
AMSC income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 4171000.00
AMSC balance_sheet (annual, 2026-03-31) — Retained Earnings: -926816000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -926816000.00
AMSC income_statement (annual, 2026-03-31) — Selling General And Administration: 57647000.00
AMSC income_statement (quarterly, 2026-03-31) — Selling General And Administration: 14596000.00
AMSC balance_sheet (annual, 2026-03-31) — Share Issued: 48035691.00
AMSC balance_sheet (quarterly, 2026-03-31) — Share Issued: 48035691.00
AMSC income_statement (annual, 2026-03-31) — Special Income Charges: -4171000.00
AMSC income_statement (quarterly, 2026-03-31) — Special Income Charges: -4171000.00
AMSC cash_flow (annual, 2026-03-31) — Stock Based Compensation: 15869000.00
AMSC cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 3755000.00
AMSC balance_sheet (annual, 2026-03-31) — Stockholders Equity: 555447000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 555447000.00
AMSC balance_sheet (annual, 2026-03-31) — Tangible Book Value: 366523000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 366523000.00
AMSC income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -1668400.00
AMSC income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -1668400.00
AMSC income_statement (annual, 2026-03-31) — Tax Provision: -117061000.00
AMSC income_statement (quarterly, 2026-03-31) — Tax Provision: -5003000.00
AMSC income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
AMSC income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
AMSC balance_sheet (annual, 2026-03-31) — Total Assets: 739481000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Total Assets: 739481000.00
AMSC balance_sheet (annual, 2026-03-31) — Total Capitalization: 555447000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 555447000.00
AMSC balance_sheet (annual, 2026-03-31) — Total Debt: 4000000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Total Debt: 4000000.00
AMSC balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 555447000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 555447000.00
AMSC income_statement (annual, 2026-03-31) — Total Expenses: 283538000.00
AMSC income_statement (quarterly, 2026-03-31) — Total Expenses: 82756000.00
AMSC balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 184034000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 184034000.00
AMSC balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 407744000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 407744000.00
AMSC balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 45507000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 45507000.00
AMSC income_statement (annual, 2026-03-31) — Total Operating Income As Reported: 11445000.00
AMSC income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -522000.00
AMSC balance_sheet (annual, 2026-03-31) — Total Tax Payable: 641000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 641000.00
AMSC income_statement (annual, 2026-03-31) — Total Unusual Items: -4171000.00
AMSC income_statement (quarterly, 2026-03-31) — Total Unusual Items: -4171000.00
AMSC income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -4171000.00
AMSC income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -4171000.00
AMSC balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 403351.00
AMSC balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 403351.00
AMSC balance_sheet (annual, 2026-03-31) — Treasury Stock: 3765000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 3765000.00
AMSC balance_sheet (annual, 2026-03-31) — Work In Process: 26873000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Work In Process: 26873000.00
AMSC balance_sheet (annual, 2026-03-31) — Working Capital: 193210000.00
AMSC balance_sheet (quarterly, 2026-03-31) — Working Capital: 193210000.00
AMSF balance_sheet (annual, 2021-12-31) — Accounts Payable: 37883000.00
AMSF cash_flow (annual, 2021-12-31) — Amortization Of Securities: 8868000.00
AMSF cash_flow (annual, 2021-12-31) — Change In Income Tax Payable: -6831000.00
AMSF cash_flow (annual, 2021-12-31) — Change In Tax Payable: -6831000.00
AMSF cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -21000.00
AMSF balance_sheet (annual, 2021-12-31) — Income Tax Payable: 0.00
AMSF balance_sheet (annual, 2021-12-31) — Payables: 37883000.00
AMSF cash_flow (annual, 2021-12-31) — Sale Of PPE: 23000.00
AMSF balance_sheet (annual, 2021-12-31) — Total Tax Payable: 0.00
AMSF income_statement (annual, 2022-12-31) — +Total Revenue: 294693000.00
AMSF balance_sheet (annual, 2022-12-31) — Accounts Payable: 38058000.00
AMSF balance_sheet (annual, 2022-12-31) — Accounts Receivable: 247390000.00
AMSF balance_sheet (annual, 2022-12-31) — Accrued Interest Receivable: 8428000.00
AMSF balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 220299000.00
AMSF cash_flow (annual, 2022-12-31) — Amortization Of Securities: 6734000.00
AMSF income_statement (annual, 2022-12-31) — Basic Average Shares: 19233241.00
AMSF income_statement (annual, 2022-12-31) — Basic EPS: 2.89
AMSF cash_flow (annual, 2022-12-31) — Beginning Cash Position: 70722000.00
AMSF cash_flow (annual, 2022-12-31) — Capital Expenditure: -2089000.00
AMSF balance_sheet (annual, 2022-12-31) — Capital Stock: 207000.00
AMSF balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 61469000.00
AMSF balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 396710000.00
AMSF cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -100427000.00
AMSF cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -112873000.00
AMSF cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 75426000.00
AMSF cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 28194000.00
AMSF cash_flow (annual, 2022-12-31) — Change In Account Payable: 969000.00
AMSF cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -2840000.00
AMSF cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 2825000.00
AMSF cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -4754000.00
AMSF cash_flow (annual, 2022-12-31) — Change In Payable: 969000.00
AMSF cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 969000.00
AMSF cash_flow (annual, 2022-12-31) — Change In Receivables: 18000000.00
AMSF cash_flow (annual, 2022-12-31) — Change In Working Capital: -41499000.00
AMSF cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 13387000.00
AMSF cash_flow (annual, 2022-12-31) — Changes In Cash: -9253000.00
AMSF balance_sheet (annual, 2022-12-31) — Common Stock: 207000.00
AMSF cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -100427000.00
AMSF balance_sheet (annual, 2022-12-31) — Common Stock Equity: 317432000.00
AMSF cash_flow (annual, 2022-12-31) — Common Stock Payments: -12388000.00
AMSF cash_flow (annual, 2022-12-31) — Deferred Income Tax: -1136000.00
AMSF cash_flow (annual, 2022-12-31) — Deferred Tax: -1136000.00
AMSF cash_flow (annual, 2022-12-31) — Depreciation: 1309000.00
AMSF cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1309000.00
AMSF income_statement (annual, 2022-12-31) — Diluted Average Shares: 19321717.00
AMSF income_statement (annual, 2022-12-31) — Diluted EPS: 2.88
AMSF income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 55602000.00
AMSF cash_flow (annual, 2022-12-31) — End Cash Position: 61469000.00
AMSF cash_flow (annual, 2022-12-31) — Financing Cash Flow: -112873000.00
AMSF cash_flow (annual, 2022-12-31) — Free Cash Flow: 26105000.00
AMSF cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -3396000.00
AMSF cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 9000.00
AMSF balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -13828000.00
AMSF income_statement (annual, 2022-12-31) — General And Administrative Expense: 26510000.00
AMSF cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 7791000.00
AMSF balance_sheet (annual, 2022-12-31) — Invested Capital: 317432000.00
AMSF cash_flow (annual, 2022-12-31) — Investing Cash Flow: 75426000.00
AMSF balance_sheet (annual, 2022-12-31) — Investments And Advances: 888987000.00
AMSF cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -58000.00
AMSF income_statement (annual, 2022-12-31) — Loss Adjustment Expense: 152316000.00
AMSF cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -12388000.00
AMSF income_statement (annual, 2022-12-31) — Net Income: 55602000.00
AMSF income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 55602000.00
AMSF income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 55602000.00
AMSF income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 55602000.00
AMSF income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 55602000.00
AMSF cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 55602000.00
AMSF income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 55602000.00
AMSF cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 77515000.00
AMSF cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -58000.00
AMSF cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -58000.00
AMSF balance_sheet (annual, 2022-12-31) — Net PPE: 7225000.00
AMSF cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -2089000.00
AMSF income_statement (annual, 2022-12-31) — Net Policyholder Benefits And Claims: 152316000.00
AMSF balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 317432000.00
AMSF income_statement (annual, 2022-12-31) — Normalized Income: 55602000.00
AMSF cash_flow (annual, 2022-12-31) — Operating Cash Flow: 28194000.00
AMSF cash_flow (annual, 2022-12-31) — Operating Gains Losses: -3387000.00
AMSF income_statement (annual, 2022-12-31) — Operating Revenue: 294693000.00
AMSF balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 19155873.00
AMSF balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -13828000.00
AMSF cash_flow (annual, 2022-12-31) — Other Non Cash Items: 6734000.00
AMSF balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 335241000.00
AMSF balance_sheet (annual, 2022-12-31) — Payables: 38058000.00
AMSF balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 38058000.00
AMSF income_statement (annual, 2022-12-31) — Policyholder Benefits Gross: 152316000.00
AMSF income_statement (annual, 2022-12-31) — Pretax Income: 67646000.00
AMSF cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
AMSF cash_flow (annual, 2022-12-31) — Purchase Of Investment: -215480000.00
AMSF cash_flow (annual, 2022-12-31) — Purchase Of PPE: -2089000.00
AMSF balance_sheet (annual, 2022-12-31) — Receivables: 257271000.00
AMSF income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1309000.00
AMSF cash_flow (annual, 2022-12-31) — Repayment Of Debt: -58000.00
AMSF cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -12388000.00
AMSF balance_sheet (annual, 2022-12-31) — Retained Earnings: 145512000.00
AMSF income_statement (annual, 2022-12-31) — Salaries And Wages: 26510000.00
AMSF cash_flow (annual, 2022-12-31) — Sale Of Investment: 292995000.00
AMSF cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
AMSF income_statement (annual, 2022-12-31) — Selling General And Administration: 26510000.00
AMSF balance_sheet (annual, 2022-12-31) — Share Issued: 20678572.00
AMSF cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2479000.00
AMSF balance_sheet (annual, 2022-12-31) — Stockholders Equity: 317432000.00
AMSF balance_sheet (annual, 2022-12-31) — Tangible Book Value: 317432000.00
AMSF income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
AMSF income_statement (annual, 2022-12-31) — Tax Provision: 12044000.00
AMSF income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.18
AMSF balance_sheet (annual, 2022-12-31) — Taxes Receivable: 1453000.00
AMSF balance_sheet (annual, 2022-12-31) — Total Assets: 1269279000.00
AMSF balance_sheet (annual, 2022-12-31) — Total Capitalization: 317432000.00
AMSF balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 317432000.00
AMSF income_statement (annual, 2022-12-31) — Total Expenses: 227047000.00
AMSF balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 951847000.00
AMSF balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 1522699.00
AMSF balance_sheet (annual, 2022-12-31) — Treasury Stock: 34758000.00
AMSF cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 8092000.00
AMSF income_statement (annual, 2023-12-31) — +Total Revenue: 306910000.00
AMSF balance_sheet (annual, 2023-12-31) — Accounts Receivable: 262824000.00
AMSF balance_sheet (annual, 2023-12-31) — Accrued Interest Receivable: 8274000.00
AMSF balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 222078000.00
AMSF income_statement (annual, 2023-12-31) — Basic Average Shares: 19149080.00
AMSF income_statement (annual, 2023-12-31) — Basic EPS: 3.24
AMSF cash_flow (annual, 2023-12-31) — Beginning Cash Position: 61469000.00
AMSF cash_flow (annual, 2023-12-31) — Capital Expenditure: -553000.00
AMSF balance_sheet (annual, 2023-12-31) — Capital Stock: 207000.00
AMSF balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 38682000.00
AMSF balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 133431000.00
AMSF cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -93307000.00
AMSF cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -96513000.00
AMSF cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 43884000.00
AMSF cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 29842000.00
AMSF cash_flow (annual, 2023-12-31) — Change In Account Payable: 306000.00
AMSF cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -1033000.00
AMSF cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 3093000.00
AMSF cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -3740000.00
AMSF cash_flow (annual, 2023-12-31) — Change In Payable: 306000.00
AMSF cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 306000.00
AMSF cash_flow (annual, 2023-12-31) — Change In Receivables: -8659000.00
AMSF cash_flow (annual, 2023-12-31) — Change In Working Capital: -31041000.00
AMSF cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -8485000.00
AMSF cash_flow (annual, 2023-12-31) — Changes In Cash: -22787000.00
AMSF balance_sheet (annual, 2023-12-31) — Common Stock: 207000.00
AMSF cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -93307000.00
AMSF balance_sheet (annual, 2023-12-31) — Common Stock Equity: 292451000.00
AMSF cash_flow (annual, 2023-12-31) — Common Stock Payments: -2171000.00
AMSF cash_flow (annual, 2023-12-31) — Deferred Income Tax: 628000.00
AMSF cash_flow (annual, 2023-12-31) — Deferred Tax: 628000.00
AMSF cash_flow (annual, 2023-12-31) — Depreciation: 1427000.00
AMSF cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1427000.00
AMSF income_statement (annual, 2023-12-31) — Diluted Average Shares: 19226021.00
AMSF income_statement (annual, 2023-12-31) — Diluted EPS: 3.23
AMSF income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 62108000.00
AMSF cash_flow (annual, 2023-12-31) — End Cash Position: 38682000.00
AMSF cash_flow (annual, 2023-12-31) — Financing Cash Flow: -96513000.00
AMSF cash_flow (annual, 2023-12-31) — Free Cash Flow: 29289000.00
AMSF cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -6636000.00
AMSF cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 2000.00
AMSF balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -7194000.00
AMSF income_statement (annual, 2023-12-31) — General And Administrative Expense: 27359000.00
AMSF cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 14912000.00
AMSF balance_sheet (annual, 2023-12-31) — Invested Capital: 292451000.00
AMSF cash_flow (annual, 2023-12-31) — Investing Cash Flow: 43884000.00
AMSF balance_sheet (annual, 2023-12-31) — Investments And Advances: 857786000.00
AMSF cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -91000.00
AMSF income_statement (annual, 2023-12-31) — Loss Adjustment Expense: 148263000.00
AMSF cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -2171000.00
AMSF income_statement (annual, 2023-12-31) — Net Income: 62108000.00
AMSF income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 62108000.00
AMSF income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 62108000.00
AMSF income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 62108000.00
AMSF income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 62108000.00
AMSF cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 62108000.00
AMSF income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 62108000.00
AMSF cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 44437000.00
AMSF cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -91000.00
AMSF cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -91000.00
AMSF balance_sheet (annual, 2023-12-31) — Net PPE: 6349000.00
AMSF cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -553000.00
AMSF income_statement (annual, 2023-12-31) — Net Policyholder Benefits And Claims: 148263000.00
AMSF balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 292451000.00
AMSF income_statement (annual, 2023-12-31) — Normalized Income: 62108000.00
AMSF cash_flow (annual, 2023-12-31) — Operating Cash Flow: 29842000.00
AMSF cash_flow (annual, 2023-12-31) — Operating Gains Losses: -6634000.00
AMSF income_statement (annual, 2023-12-31) — Operating Revenue: 306910000.00
AMSF balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 19135008.00
AMSF balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -7194000.00
AMSF cash_flow (annual, 2023-12-31) — Other Non Cash Items: 3025000.00
AMSF balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 94749000.00
AMSF balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 0.00
AMSF income_statement (annual, 2023-12-31) — Policyholder Benefits Gross: 148263000.00
AMSF income_statement (annual, 2023-12-31) — Pretax Income: 77377000.00
AMSF cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: -944000.00
AMSF cash_flow (annual, 2023-12-31) — Purchase Of Investment: -133678000.00
AMSF cash_flow (annual, 2023-12-31) — Purchase Of PPE: -553000.00
AMSF balance_sheet (annual, 2023-12-31) — Receivables: 272879000.00
AMSF income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1427000.00
AMSF cash_flow (annual, 2023-12-31) — Repayment Of Debt: -91000.00
AMSF cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -2171000.00
AMSF balance_sheet (annual, 2023-12-31) — Retained Earnings: 114289000.00
AMSF income_statement (annual, 2023-12-31) — Salaries And Wages: 27359000.00
AMSF cash_flow (annual, 2023-12-31) — Sale Of Investment: 178115000.00
AMSF cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
AMSF income_statement (annual, 2023-12-31) — Selling General And Administration: 27359000.00
AMSF balance_sheet (annual, 2023-12-31) — Share Issued: 20704448.00
AMSF cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1557000.00
AMSF balance_sheet (annual, 2023-12-31) — Stockholders Equity: 292451000.00
AMSF balance_sheet (annual, 2023-12-31) — Tangible Book Value: 292451000.00
AMSF income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
AMSF income_statement (annual, 2023-12-31) — Tax Provision: 15269000.00
AMSF income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.20
AMSF balance_sheet (annual, 2023-12-31) — Taxes Receivable: 1781000.00
AMSF balance_sheet (annual, 2023-12-31) — Total Assets: 1229162000.00
AMSF balance_sheet (annual, 2023-12-31) — Total Capitalization: 292451000.00
AMSF balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 292451000.00
AMSF income_statement (annual, 2023-12-31) — Total Expenses: 229533000.00
AMSF balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 936711000.00
AMSF balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 1569440.00
AMSF balance_sheet (annual, 2023-12-31) — Treasury Stock: 36929000.00
AMSF cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -1228000.00
AMSF cash_flow (quarterly, 2024-09-30) — Amortization Of Securities: 229000.00
AMSF cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 0.00
AMSF income_statement (annual, 2024-12-31) — +Total Revenue: 309109000.00
AMSF balance_sheet (annual, 2024-12-31) — Accounts Receivable: 259678000.00
AMSF balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 7327000.00
AMSF balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 223956000.00
AMSF income_statement (annual, 2024-12-31) — Basic Average Shares: 19070717.00
AMSF income_statement (annual, 2024-12-31) — Basic EPS: 2.91
AMSF cash_flow (annual, 2024-12-31) — Beginning Cash Position: 38682000.00
AMSF cash_flow (annual, 2024-12-31) — Capital Expenditure: -840000.00
AMSF balance_sheet (annual, 2024-12-31) — Capital Stock: 207000.00
AMSF balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 44045000.00
AMSF balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 130551000.00
AMSF cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -85436000.00
AMSF cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -91198000.00
AMSF cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 72371000.00
AMSF cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 24190000.00
AMSF cash_flow (annual, 2024-12-31) — Change In Account Payable: -2232000.00
AMSF cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 6688000.00
AMSF cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -15692000.00
AMSF cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 11926000.00
AMSF cash_flow (annual, 2024-12-31) — Change In Payable: -2232000.00
AMSF cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -2232000.00
AMSF cash_flow (annual, 2024-12-31) — Change In Receivables: -11508000.00
AMSF cash_flow (annual, 2024-12-31) — Change In Working Capital: -29338000.00
AMSF cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -12056000.00
AMSF cash_flow (annual, 2024-12-31) — Changes In Cash: 5363000.00
AMSF balance_sheet (annual, 2024-12-31) — Common Stock: 207000.00
AMSF cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -85436000.00
AMSF balance_sheet (annual, 2024-12-31) — Common Stock Equity: 257341000.00
AMSF cash_flow (annual, 2024-12-31) — Common Stock Payments: -5123000.00
AMSF cash_flow (annual, 2024-12-31) — Deferred Income Tax: 1402000.00
AMSF cash_flow (annual, 2024-12-31) — Deferred Tax: 1402000.00
AMSF cash_flow (annual, 2024-12-31) — Depreciation: 1093000.00
AMSF cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1093000.00
AMSF income_statement (annual, 2024-12-31) — Diluted Average Shares: 19159805.00
AMSF income_statement (annual, 2024-12-31) — Diluted EPS: 2.89
AMSF income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 55436000.00
AMSF cash_flow (annual, 2024-12-31) — End Cash Position: 44045000.00
AMSF cash_flow (annual, 2024-12-31) — Financing Cash Flow: -91198000.00
AMSF cash_flow (annual, 2024-12-31) — Free Cash Flow: 23350000.00
AMSF cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 510000.00
AMSF cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 209000.00
AMSF cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
AMSF balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -8875000.00
AMSF income_statement (annual, 2024-12-31) — General And Administrative Expense: 31503000.00
AMSF cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 12849000.00
AMSF balance_sheet (annual, 2024-12-31) — Invested Capital: 257341000.00
AMSF cash_flow (annual, 2024-12-31) — Investing Cash Flow: 72371000.00
AMSF balance_sheet (annual, 2024-12-31) — Investments And Advances: 788778000.00
AMSF cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -85000.00
AMSF income_statement (annual, 2024-12-31) — Loss Adjustment Expense: 157267000.00
AMSF cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -5123000.00
AMSF income_statement (annual, 2024-12-31) — Net Income: 55436000.00
AMSF income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 55436000.00
AMSF income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 55436000.00
AMSF income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 55436000.00
AMSF income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 55436000.00
AMSF cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 55436000.00
AMSF income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 55436000.00
AMSF cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 73211000.00
AMSF cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -85000.00
AMSF cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -85000.00
AMSF balance_sheet (annual, 2024-12-31) — Net PPE: 5887000.00
AMSF cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -840000.00
AMSF income_statement (annual, 2024-12-31) — Net Policyholder Benefits And Claims: 157267000.00
AMSF balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 257341000.00
AMSF income_statement (annual, 2024-12-31) — Normalized Income: 55436000.00
AMSF cash_flow (annual, 2024-12-31) — Operating Cash Flow: 24190000.00
AMSF cash_flow (annual, 2024-12-31) — Operating Gains Losses: 719000.00
AMSF income_statement (annual, 2024-12-31) — Operating Revenue: 309109000.00
AMSF balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 19050315.00
AMSF balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -8875000.00
AMSF cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1447000.00
AMSF balance_sheet (annual, 2024-12-31) — Other Payable: 1430000.00
AMSF balance_sheet (quarterly, 2024-12-31) — Other Payable: 1430000.00
AMSF balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 86506000.00
AMSF balance_sheet (annual, 2024-12-31) — Payables: 1430000.00
AMSF balance_sheet (quarterly, 2024-12-31) — Payables: 1430000.00
AMSF balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1430000.00
AMSF income_statement (annual, 2024-12-31) — Policyholder Benefits Gross: 157267000.00
AMSF income_statement (annual, 2024-12-31) — Pretax Income: 69056000.00
AMSF cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: -554000.00
AMSF cash_flow (annual, 2024-12-31) — Purchase Of Investment: -110699000.00
AMSF cash_flow (annual, 2024-12-31) — Purchase Of PPE: -840000.00
AMSF balance_sheet (annual, 2024-12-31) — Receivables: 269185000.00
AMSF income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1093000.00
AMSF cash_flow (annual, 2024-12-31) — Repayment Of Debt: -85000.00
AMSF cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -5123000.00
AMSF balance_sheet (annual, 2024-12-31) — Retained Earnings: 84105000.00
AMSF income_statement (annual, 2024-12-31) — Salaries And Wages: 31503000.00
AMSF cash_flow (annual, 2024-12-31) — Sale Of Investment: 183910000.00
AMSF income_statement (annual, 2024-12-31) — Selling General And Administration: 31503000.00
AMSF balance_sheet (annual, 2024-12-31) — Share Issued: 20733166.00
AMSF cash_flow (annual, 2024-12-31) — Stock Based Compensation: 2939000.00
AMSF balance_sheet (annual, 2024-12-31) — Stockholders Equity: 257341000.00
AMSF balance_sheet (annual, 2024-12-31) — Tangible Book Value: 257341000.00
AMSF income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
AMSF income_statement (annual, 2024-12-31) — Tax Provision: 13620000.00
AMSF income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.20
AMSF balance_sheet (annual, 2024-12-31) — Taxes Receivable: 2180000.00
AMSF balance_sheet (annual, 2024-12-31) — Total Assets: 1157791000.00
AMSF balance_sheet (annual, 2024-12-31) — Total Capitalization: 257341000.00
AMSF balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 257341000.00
AMSF income_statement (annual, 2024-12-31) — Total Expenses: 240053000.00
AMSF balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 900450000.00
AMSF balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 1682851.00
AMSF balance_sheet (annual, 2024-12-31) — Treasury Stock: 42052000.00
AMSF cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -9508000.00
AMSF income_statement (quarterly, 2025-03-31) — +Total Revenue: 72613000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 271024000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Accrued Interest Receivable: 7747000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 224327000.00
AMSF cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 261000.00
AMSF income_statement (quarterly, 2025-03-31) — Basic Average Shares: 19036309.00
AMSF income_statement (quarterly, 2025-03-31) — Basic EPS: 0.47
AMSF cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 44045000.00
AMSF cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -2000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Capital Stock: 207000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 44753000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 138065000.00
AMSF cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -7424000.00
AMSF cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -7445000.00
AMSF cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 9945000.00
AMSF cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1792000.00
AMSF cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -234000.00
AMSF cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 1772000.00
AMSF cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -5301000.00
AMSF cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 2741000.00
AMSF cash_flow (quarterly, 2025-03-31) — Change In Payable: -234000.00
AMSF cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -234000.00
AMSF cash_flow (quarterly, 2025-03-31) — Change In Receivables: -12415000.00
AMSF cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -15332000.00
AMSF cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -14079000.00
AMSF cash_flow (quarterly, 2025-03-31) — Changes In Cash: 708000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Common Stock: 207000.00
AMSF cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -7424000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 260813000.00
AMSF cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
AMSF cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -91000.00
AMSF cash_flow (quarterly, 2025-03-31) — Deferred Tax: -91000.00
AMSF cash_flow (quarterly, 2025-03-31) — Depreciation: 214000.00
AMSF cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 214000.00
AMSF income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 19154426.00
AMSF income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.47
AMSF income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 8949000.00
AMSF cash_flow (quarterly, 2025-03-31) — End Cash Position: 44753000.00
AMSF cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -7445000.00
AMSF cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1794000.00
AMSF cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -18000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -7269000.00
AMSF income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 8284000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Invested Capital: 260813000.00
AMSF cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 9945000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 781012000.00
AMSF cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -21000.00
AMSF income_statement (quarterly, 2025-03-31) — Loss Adjustment Expense: 40159000.00
AMSF cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
AMSF income_statement (quarterly, 2025-03-31) — Net Income: 8949000.00
AMSF income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 8949000.00
AMSF income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 8949000.00
AMSF income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 8949000.00
AMSF income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 8949000.00
AMSF cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 8949000.00
AMSF income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 8949000.00
AMSF cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 9947000.00
AMSF cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -21000.00
AMSF cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -21000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Net PPE: 5675000.00
AMSF cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -2000.00
AMSF income_statement (quarterly, 2025-03-31) — Net Policyholder Benefits And Claims: 40159000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 260813000.00
AMSF income_statement (quarterly, 2025-03-31) — Normalized Income: 8949000.00
AMSF cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1792000.00
AMSF cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -18000.00
AMSF income_statement (quarterly, 2025-03-31) — Operating Revenue: 72613000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 19050315.00
AMSF balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -7269000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Other Payable: 2324000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 93312000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Payables: 2324000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 2324000.00
AMSF income_statement (quarterly, 2025-03-31) — Policyholder Benefits Gross: 40159000.00
AMSF income_statement (quarterly, 2025-03-31) — Pretax Income: 11221000.00
AMSF cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -10498000.00
AMSF cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -2000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Receivables: 278867000.00
AMSF income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 214000.00
AMSF cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -21000.00
AMSF cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
AMSF balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 85600000.00
AMSF income_statement (quarterly, 2025-03-31) — Salaries And Wages: 8284000.00
AMSF cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 20445000.00
AMSF income_statement (quarterly, 2025-03-31) — Selling General And Administration: 8284000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Share Issued: 20733166.00
AMSF cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1073000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 260813000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 260813000.00
AMSF income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AMSF income_statement (quarterly, 2025-03-31) — Tax Provision: 2272000.00
AMSF income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.20
AMSF balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 96000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Total Assets: 1156717000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 260813000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 260813000.00
AMSF income_statement (quarterly, 2025-03-31) — Total Expenses: 61392000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 895904000.00
AMSF balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 1682851.00
AMSF balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 42052000.00
AMSF cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 3152000.00
AMSF income_statement (quarterly, 2025-06-30) — +Total Revenue: 81100000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 282115000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Accrued Interest Receivable: 7458000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 225674000.00
AMSF cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: 185000.00
AMSF income_statement (quarterly, 2025-06-30) — Basic Average Shares: 19038360.00
AMSF income_statement (quarterly, 2025-06-30) — Basic EPS: 0.73
AMSF cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 44753000.00
AMSF cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1082000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Capital Stock: 208000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 48465000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 140459000.00
AMSF cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -7486000.00
AMSF cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -10976000.00
AMSF cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 23131000.00
AMSF cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -8443000.00
AMSF cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 3917000.00
AMSF cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -1123000.00
AMSF cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 2722000.00
AMSF cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -1493000.00
AMSF cash_flow (quarterly, 2025-06-30) — Change In Payable: 3917000.00
AMSF cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 3917000.00
AMSF cash_flow (quarterly, 2025-06-30) — Change In Receivables: -11245000.00
AMSF cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -17681000.00
AMSF cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -9235000.00
AMSF cash_flow (quarterly, 2025-06-30) — Changes In Cash: 3712000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Common Stock: 208000.00
AMSF cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -7486000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 265570000.00
AMSF cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -2796000.00
AMSF cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -883000.00
AMSF cash_flow (quarterly, 2025-06-30) — Deferred Tax: -883000.00
AMSF cash_flow (quarterly, 2025-06-30) — Depreciation: 195000.00
AMSF cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 195000.00
AMSF income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 19119600.00
AMSF income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.73
AMSF income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 13955000.00
AMSF cash_flow (quarterly, 2025-06-30) — End Cash Position: 48465000.00
AMSF cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -10976000.00
AMSF cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -9525000.00
AMSF cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -3128000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -7561000.00
AMSF income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 7459000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Invested Capital: 265570000.00
AMSF cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 23131000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 758888000.00
AMSF cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -21000.00
AMSF income_statement (quarterly, 2025-06-30) — Loss Adjustment Expense: 40660000.00
AMSF cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -2796000.00
AMSF income_statement (quarterly, 2025-06-30) — Net Income: 13955000.00
AMSF income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 13955000.00
AMSF income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 13955000.00
AMSF income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 13955000.00
AMSF income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 13955000.00
AMSF cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 13955000.00
AMSF income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 13955000.00
AMSF cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 24213000.00
AMSF cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -21000.00
AMSF cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -21000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Net PPE: 6563000.00
AMSF cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1082000.00
AMSF income_statement (quarterly, 2025-06-30) — Net Policyholder Benefits And Claims: 40660000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 265570000.00
AMSF income_statement (quarterly, 2025-06-30) — Normalized Income: 13955000.00
AMSF cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -8443000.00
AMSF cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -3128000.00
AMSF income_statement (quarterly, 2025-06-30) — Operating Revenue: 81100000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 19018747.00
AMSF balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -7561000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Other Payable: 41000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 91994000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Payables: 41000.00